Matches in Wikidata for { <http://www.wikidata.org/entity/Q99081290> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q99081290 description "clinical trial" @default.
- Q99081290 description "ensayo clínico" @default.
- Q99081290 description "ensayu clínicu" @default.
- Q99081290 description "klinisch onderzoek" @default.
- Q99081290 description "клінічне випробування" @default.
- Q99081290 description "临床试验" @default.
- Q99081290 name "Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma" @default.
- Q99081290 name "Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma" @default.
- Q99081290 type Item @default.
- Q99081290 label "Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma" @default.
- Q99081290 label "Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma" @default.
- Q99081290 prefLabel "Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma" @default.
- Q99081290 prefLabel "Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma" @default.
- Q99081290 P1050 Q99081290-D1DDB08B-9590-462C-B128-A7C2B34BEE12 @default.
- Q99081290 P1132 Q99081290-1EC2C18C-29CF-497F-A4F6-CD37DA526791 @default.
- Q99081290 P1476 Q99081290-5B1B071F-D7D8-4EF3-9770-8E9759D12488 @default.
- Q99081290 P17 Q99081290-81A56930-DA98-49E8-AD4B-EB760510B56F @default.
- Q99081290 P2899 Q99081290-0324632D-40E8-4168-A527-C5B5998614C3 @default.
- Q99081290 P3098 Q99081290-E2FD72EC-B0AC-4C54-B8BE-05D46EC8BA1D @default.
- Q99081290 P31 Q99081290-4106EFEA-2C51-4F99-88B7-050F4E13D97F @default.
- Q99081290 P580 Q99081290-EBCB60EE-DD3C-4EA3-B2EA-F8C8E4AD90B6 @default.
- Q99081290 P582 Q99081290-FA11C71D-7B82-4553-B2C3-F296E27281F7 @default.
- Q99081290 P6099 Q99081290-1CF8647B-19C1-465C-9CD9-37F25D7E15A6 @default.
- Q99081290 P8005 Q99081290-3409E49D-D95B-4624-A2CE-222272A23222 @default.
- Q99081290 P8363 Q99081290-5DC08353-6D9D-4177-B3EA-536261D7512E @default.
- Q99081290 P859 Q99081290-6C53A625-BA0C-4E00-A3E1-9B0C7FB21C52 @default.
- Q99081290 P1050 Q208414 @default.
- Q99081290 P1132 "+24" @default.
- Q99081290 P1476 "Ublituximab as Initial Therapy for Treatment-naive Follicular or Marginal Zone Lymphoma With Response-driven Addition of Umbralisib for Suboptimal Response" @default.
- Q99081290 P17 Q30 @default.
- Q99081290 P2899 "+18" @default.
- Q99081290 P3098 "NCT04508647" @default.
- Q99081290 P31 Q30612 @default.
- Q99081290 P580 "2020-12-01T00:00:00Z" @default.
- Q99081290 P582 "2023-07-01T00:00:00Z" @default.
- Q99081290 P6099 Q42824440 @default.
- Q99081290 P8005 Q76649614 @default.
- Q99081290 P8363 Q78089383 @default.
- Q99081290 P859 Q1468161 @default.